Wednesday, December 30, 2009

Pfizer Stops Lung Cancer Study - Zacks.com


Pfizer Stops Lung Cancer Study
Zacks.com
The discontinuation of the lung cancer study resulted in Pfizer's shares losing 4 cents at 18.52 in after-hours trading on Dec 29. ...

and more »

No comments:

Post a Comment